Jens Thomas Siveke (Jens T Siveke, Jens Siveke)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 57

Top Venues

Nature

Nature communications

Current oncology (Toronto, Ont.)

Clinical cancer research : an official journal of the American Association for Cancer Research

Essen University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Essen University Hospital

Germany

Director :: Institute for Developmental Cancer Therapeutics

German Cancer Research Center

Germany

Director :: Division of Solid Tumor Translational Oncology

Publications

I-Na Lu, Phyllis Fung-Yi Cheung, Michael Heming, Christian Thomas, Giovanni Giglio, Markus Leo, Merve Erdemir, Timo Wirth, Simone König, Christine A Dambietz, Christina B Schroeter, Christopher Nelke, Jens Thomas Siveke, Tobias Ruck, Luisa Klotz, Carmen Haider, Romana Höftberger, Christoph Kleinschnitz, Heinz Wiendl, Tim Hagenacker, Gerd Meyer Zu Hörste
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment. Nature communications 15 (1) (2024)
I-Na Lu, Phyllis Fung-Yi Cheung, Michael Heming, Christian Thomas, Giovanni Giglio, Markus Leo, Merve Erdemir, Timo Wirth, Simone König, Christine A Dambietz, Christina B Schroeter, Christopher Nelke, Jens Thomas Siveke, Tobias Ruck, Luisa Klotz, Carmen Haider, Romana Höftberger, Christoph Kleinschnitz, Heinz Wiendl, Tim Hagenacker, Gerd Meyer Zu Hörste
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment. Nature communications 15 (1) (2024)
Nico De Lazzari, Miriam Götte, Stefan Kasper, Eileen Meier, Martin Schuler, Michael Pogorzelski, Jens Thomas Siveke, Mitra Tewes
P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (7) (2024)
I-Na Lu, Phyllis Fung-Yi Cheung, Michael Heming, Christian Thomas, Giovanni Giglio, Markus Leo, Merve Erdemir, Timo Wirth, Simone König, Christine A Dambietz, Christina B Schroeter, Christopher Nelke, Jens Thomas Siveke, Tobias Ruck, Luisa Klotz, Carmen Haider, Romana Höftberger, Christoph Kleinschnitz, Heinz Wiendl, Tim Hagenacker, Gerd Meyer Zu Hörste
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment. Nature communications 15 (1) (2024)
Nico De Lazzari, Miriam Götte, Stefan Kasper, Eileen Meier, Martin Schuler, Michael Pogorzelski, Jens Thomas Siveke, Mitra Tewes
P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (7) (2024)
Nico De Lazzari, Miriam Götte, Stefan Kasper, Eileen Meier, Martin Schuler, Michael Pogorzelski, Jens Thomas Siveke, Mitra Tewes
P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (7) (2024)
Donald P Cameron, Jan Grosser, Swetlana Ladigan-Badura, Vladislav Kuzin, Evanthia Iliopoulou, Anika Wiegard, Hajar Benredjem, Kathryn Jackson, Sven T Liffers, Smiths S Lueong, Phyllis Fung-Yi Cheung, Deepak Ben Vangala, Michael Pohl, Richard Viebahn, Christian Teschendorf, Heiner Wolters, Selami Usta, Keyi Geng, Claudia Kutter, Marie Arsenian Henriksson, Jens Thomas Siveke, Andrea Tannapfel, Wolff Schmiegel, Stephan A Hahn, Laura Baranello
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription. Science advances 9 (41) (2023)
Xin Wang, Ana Patricia Kutschat, Joana Aggrey-Fynn, Feda H Hamdan, Rondell P Graham, Alexander Q Wixom, Yara Souto, Swetlana Ladigan-Badura, Jennifer A Yonkus, Amro M Abdelrahman, Roberto Alva-Ruiz, Jochen Gaedcke, Philipp Stroebel, Robyn Laura Kosinsky, Florian Wegwitz, Patrick Christian Hermann, Mark J Truty, Jens Thomas Siveke, Stephan A Hahn, Elisabeth Hessmann, Steven A Johnsen, Zeynab Najafova
Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma. Molecular cancer research : MCR (2023)
Dirk Tomsitz, Theresa Ruf, Markus Vincent Heppt, Ramon Staeger, Egle Ramelyte, Reinhard Dummer, Marlene Garzarolli, Friedegund Meier, Eileen Meier, Heike Richly, Tanja Gromke, Jens Thomas Siveke, Cindy Franklin, Kai-Christian Klespe, Cornelia Mauch, Teresa Kilian, Marlene Seegräber, Bastian Schilling, Lars E French, Carola Berking, Lucie Heinzerling
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study. Cancers 15 (13) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Oihane Erice, Shruthi Narayanan, Iker Feliu, Rodrigo Entrialgo-Cadierno, Antonia Malinova, Caterina Vicentini, Elisabeth Guruceaga, Pietro Delfino, Marija Trajkovic-Arsic, Haritz Moreno, Karmele Valencia, Ester Blanco, Irati Macaya, Daniel Öhlund, Purvesh Khatri, Fernando Lecanda, Aldo Scarpa, Jens Thomas Siveke, Vincenzo Corbo, Mariano Ponz-Sarvisé, Silvestre Vincent
Lamc2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Oihane Erice, Shruthi Narayanan, Iker Feliu, Rodrigo Entrialgo-Cadierno, Antonia Malinova, Caterina Vicentini, Elisabeth Guruceaga, Pietro Delfino, Marija Trajkovic-Arsic, Haritz Moreno, Karmele Valencia, Ester Blanco, Irati Macaya, Daniel Öhlund, Purvesh Khatri, Fernando Lecanda, Aldo Scarpa, Jens Thomas Siveke, Vincenzo Corbo, Mariano Ponz-Sarvisé, Silvestre Vincent
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature (2023)
Melissa Barroux, Jacob Househam, Eszter Lakatos, Tahel Ronel, Ann-Marie C Baker, Henrike Sali, Max Mossner, Kane Smith, Chris Kimberley, Salpie Nowinski, Alison Berner, Vinaya Gunasri, Marnix Jansen, Giulio Caravagna, Katja Steiger, Julia Slotta-Huspenina, Wilko Weichert, Markus Alberstmeier, Benjamin M Chain, Helmut Friess, Bertram Bengsch, Roland Schmid, Jens Thomas Siveke, Michael Quante, Trevor A Graham
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma. Research square (2023)
Feda H Hamdan, Amro M Abdelrahman, Ana Patricia Kutschat, Xin Wang, Thomas L Ekstrom, Nidhi Jalan-Sakrikar, Catherine Wegner Wippel, Negar Taheri, Liezel Tamon, Waltraut Kopp, Joana Aggrey-Fynn, Aditya V Bhagwate, Roberto Alva-Ruiz, Isaac Lynch, Jennifer Yonkus, Robyn Laura Kosinsky, Jochen Gaedcke, Stephan A Hahn, Jens Thomas Siveke, Rondell Graham, Zeynab Najafova, Elisabeth Hessmann, Mark J Truty, Steven A Johnsen
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer. Gut (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Oihane Erice, Shruthi Narayanan, Iker Feliu, Rodrigo Entrialgo-Cadierno, Antonia Malinova, Caterina Vicentini, Elisabeth Guruceaga, Pietro Delfino, Marija Trajkovic-Arsic, Haritz Moreno, Karmele Valencia, Ester Blanco, Irati Macaya, Daniel Öhlund, Purvesh Khatri, Fernando Lecanda, Aldo Scarpa, Jens Thomas Siveke, Vincenzo Corbo, Mariano Ponz-Sarvisé, Silvestre Vincent
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Nicolas Hohmann, Martin Ronald Sprick, Azaz Ahmed, Juergen Burhenne, Marietta Kirchner, Lucian Le Cornet, Markus Kratzmann, Jacek Hajda, Albrecht Stenzinger, Karen Steindorf, Stefan Delorme, Heinz-Peter Schlemmer, Sabine Riethdorf, Ron van Schaik, Klaus Pantel, Jens Thomas Siveke, Thomas Seufferlein, Dirk Jäger, Walter Emil Haefeli, Flavia Carla Meotti, Christoph Springfeld
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy. Clinical and translational science (2023)
Esther M M Smeets, Daphne N Dorst, Gerben M Franssen, Merijn S van Essen, Cathelijne Frielink, Martijn W J Stommel, Marija Trajkovic-Arsic, Phyllis F Cheung, Jens Thomas Siveke, Ian Wilson, Alessandro Mascioni, Erik H J G Aarntzen, Sanne A M van Lith
Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy. Cells 12 (10) (2023)
Melissa Barroux, Jacob Househam, Eszter Lakatos, Tahel Ronel, Ann-Marie C Baker, Henrike Sali, Max Mossner, Kane Smith, Chris Kimberley, Salpie Nowinski, Alison Berner, Vinaya Gunasri, Marnix Jansen, Giulio Caravagna, Katja Steiger, Julia Slotta-Huspenina, Wilko Weichert, Markus Alberstmeier, Benjamin M Chain, Helmut Friess, Bertram Bengsch, Roland Schmid, Jens Thomas Siveke, Michael Quante, Trevor A Graham
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma. Research square (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Melissa Barroux, Jacob Househam, Eszter Lakatos, Tahel Ronel, Ann-Marie C Baker, Henrike Sali, Max Mossner, Kane Smith, Chris Kimberley, Salpie Nowinski, Alison Berner, Vinaya Gunasri, Marnix Jansen, Giulio Caravagna, Katja Steiger, Julia Slotta-Huspenina, Wilko Weichert, Markus Alberstmeier, Benjamin M Chain, Helmut Friess, Bertram Bengsch, Roland Schmid, Jens Thomas Siveke, Michael Quante, Trevor A Graham
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma. Research square (2023)
Melissa Barroux, Jacob Househam, Eszter Lakatos, Tahel Ronel, Ann-Marie C Baker, Henrike Sali, Max Mossner, Kane Smith, Chris Kimberley, Salpie Nowinski, Alison Berner, Vinaya Gunasri, Marnix Jansen, Giulio Caravagna, Katja Steiger, Julia Slotta-Huspenina, Wilko Weichert, Markus Alberstmeier, Benjamin M Chain, Helmut Friess, Bertram Bengsch, Roland Schmid, Jens Thomas Siveke, Michael Quante, Trevor A Graham
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma. Research square (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Joseph Tintelnot, Yang Xu, Till R Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D Giannou, Penelope Pelczar, Dominik Kylies, Victor G Puelles, Agata A Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S Bröring, Marija Trajkovic-Arsic, Jens Thomas Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G Uzunoglu, Cenap Güngör, Alexander Stein, Jakob R Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C Kimmelman, Samuel Huber, Nicola Gagliani
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615 (7950) (2023)
Fabian Hörst, Saskia Ting, Sven-Thorsten Liffers, Kelsey L Pomykala, Katja Steiger, Markus Albertsmeier, Martin K Angele, Sylvie Lorenzen, Michael Quante, Wilko Weichert, Jan Egger, Jens Thomas Siveke, Jens Kleesiek
Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning. JCO clinical cancer informatics 7 (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Sied Kebir, Vivien Ullrich, Pia Berger, Celia Dobersalske, Sarah Langer, Laurèl Rauschenbach, Daniel Trageser, Andreas Till, Franziska K Lorbeer, Anja Wieland, Timo Wilhelm-Buchstab, Ashar Ahmad, Holger Fröhlich, Igor Cima, Shruthi Prasad, Johann Matschke, Verena Jendrossek, Marc Remke, Barbara M Grüner, Alexander Roesch, Jens Thomas Siveke, Christel Herold-Mende, Tobias Blau, Kathy Keyvani, Frank K H van Landeghem, Torsten Pietsch, Jörg Felsberg, Guido Reifenberger, Michael Weller, Ulrich Sure, Oliver Brüstle, Matthias Simon, Martin Glas, Björn Scheffler
A sequential targeting strategy interrupts AKT-driven subclone-mediated progression in glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Wolfgang Peter Fendler, Kim Magaly Pabst, Lukas Kessler, Pedro Fragoso Costa, Justin Ferdinandus, Manuel Weber, Maria Lippert, Katharina Lückerath, Lale Umutlu, Karina Kostbade, Ilektra A Mavroeidi, Martin Schuler, Marit Ahrens, Christoph Rischpler, Sebastian Bauer, Ken Herrmann, Jens Thomas Siveke, Rainer Hamacher
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Timm M Reissig, Sebastian Uhrig, Philipp J Jost, Claudio Luchini, Caterina Vicentini, Sven-Thorsten Liffers, Michael Allgäuer, Volkan Adsay, Aldo Scarpa, Rita Teresa Lawlor, Stefan Fröhling, Albrecht Stenzinger, Günter Klöppel, Hans-Ulrich Schildhaus, Jens Thomas Siveke
MCL1 as putative target in pancreatoblastoma. Virchows Archiv : an international journal of pathology 481 (2) (2022)
Alexandr V Bazhin, Katharina von Ahn, Jasmin Fritz, Henriette Bunge, Caroline Maier, Orkhan Isayev, Florian Neff, Jens Thomas Siveke, Svetlana Karakhanova
Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer. Oncoimmunology 11 (1) (2022)
Phyllis F Cheung, JiaJin Yang, Rui Fang, Arianna Borgers, Kirsten Krengel, Anne Stoffel, Kristina Althoff, Chi Wai Yip, Elaine H L Siu, Linda W C Ng, Karl S Lang, Lamin B Cham, Daniel R Engel, Camille Soun, Igor Cima, Björn Scheffler, Jana K Striefler, Marianne Sinn, Marcus Bahra, Uwe Pelzer, Helmut Oettle, Peter Markus, Esther M M Smeets, Erik H J G Aarntzen, Konstantinos Savvatakis, Sven-Thorsten Liffers, Smiths S Lueong, Christian Neander, Anna Bazarna, Xin Zhang, Annette Paschen, Howard C Crawford, Anthony W H Chan, Siu Tim Cheung, Jens Thomas Siveke
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Nature communications 13 (1) (2022)
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M Pabst, Francesco Barbato, Katharina Lückerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kuemmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Gruenwald, Jens Thomas Siveke, Ken Herrmann, Wolfgang Peter Fendler
Fibroblast activation protein positron emission tomography and histopathology in a single-center database of 324 patients and 21 tumor entities. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David F Ast, Alena Heimsoeth, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Marcel A Dammert, Dennis Plenker, Sebastian Klein, Philipp Lohneis, Jianing Gu, Laura K Godfrey, Jan Forster, Marija Trajkovic-Arsic, Thomas Zillinger, Mareike Haarmann, Alexander Quaas, Stefanie Lennartz, Marcel Schmiel, Joshua D'Rozario, Emily S Thomas, Qi-Xiang Li, Clemens A Schmitt, Julie George, Roman K Thomas, Silvia von Karstedt, Gunther Hartmann, Reinhard Buttner, Roland T Ullrich, Jens Thomas Siveke, Kadoaki Ohashi, Martin Schlee, Martin L Sos
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nature communications 12 (1) (2021)
Inna Schott, Sven-Thorsten Liffers, Farhad Farzaliyev, Johanna Falkenhorst, Hans-Ulrich Steinau, Jürgen-Walter Treckmann, Lars Erik Podleska, Christoph Pöttgen, Hans-Ulrich Schildhaus, Marit Ahrens, Uta Dirksen, Fatma-Zehra Murat, Jens Thomas Siveke, Sebastian Bauer, Rainer Hamacher
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology. Sarcoma 2021 (2021)
Na Sun, Marija Trajkovic-Arsic, Fengxia Li, Yin Wu, Corinna Münch, Thomas Kunzke, Annette Feuchtinger, Katja Steiger, Anna Melissa Schlitter, Wilko Weichert, Irene Esposito, Jens Thomas Siveke, Axel Walch
Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma. EJNMMI research 11 (1) (2021)
Julia Pohl, Raluca-Ileana Mincu, Simone M Mrotzek, Reza Wakili, Amir Abbas Mahabadi, Sophia K Potthoff, Jens Thomas Siveke, Ulrich Bernd Keller, Ulf Landmesser, Tienush Rassaf, Markus S Anker, Matthias Totzeck
ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity. Cancers 13 (6) (2021)
Svenja Mergener, Jens Thomas Siveke, Samuel Peña-Llopis
Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma. International journal of molecular sciences 22 (13) (2021)
Justin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, Manuel Weber, Nader Hirmas, Karina Kostbade, Sebastian Bauer, Martin Schuler, Marit Ahrens, Hans-Ulrich Schildhaus, Christoph Rischpler, Hong Grafe, Jens Thomas Siveke, Ken Herrmann, Wolfgang Peter Fendler, Rainer Hamacher
Initial clinical experience with 90Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Vivian Rosery, Henning Reis, Konstantinos Savvatakis, Bernd Kowall, Martin Stuschke, Andreas Paul, Alexander Dechêne, JiaJin Yang, Ben Zhao, Arianna Borgers, Stefan Kasper, Martin Schuler, Phyllis F Cheung, Jens Thomas Siveke
Antitumor immune response is associated with favorable survival in GEP-NEN G3. Endocrine-related cancer 28 (10) (2021)
Lena Quambusch, Laura Depta, Ina Landel, Melissa Lubeck, Tonia Kirschner, Jonas Nabert, Niklas Uhlenbrock, Jörn Weisner, Michael Kostka, Laura M Levy, Carsten Schultz-Fademrecht, Franziska Glanemann, Kristina Althoff, Matthias P Müller, Jens Thomas Siveke, Daniel Rauh
Cellular model system to dissect the isoform-selectivity of Akt inhibitors. Nature communications 12 (1) (2021)
Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Mock, Jennifer Hüllein, Martina Fröhlich, Sebastian Uhrig, Arne Jahn, Andreas Rump, Laura Gieldon, Lino Möhrmann, Dorothea Hanf, Veronica Teleanu, Christoph E Heilig, Daniel B Lipka, Michael Allgäuer, Leo Ruhnke, Andreas Laßmann, Volker Endris, Olaf Neumann, Roland Penzel, Katja Beck, Daniela Richter, Ulrike Winter, Stephan Wolf, Katrin Pfütze, Christina Geörg, Bettina Meißburger, Ivo Buchhalter, Marinela Augustin, Walter E Aulitzky, Peter Hohenberger, Matthias Kroiss, Peter Schirmacher, Richard F Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens Thomas Siveke, Christian H Brandts, Thomas Kindler, Melanie Börries, Anna L Illert, Nikolas von Bubnoff, Philipp J Jost, Karsten Spiekermann, Michael Bitzer, Klaus Schulze-Osthoff, Christof von Kalle, Barbara Klink, Benedikt Brors, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Wilko Weichert, Hanno Glimm, Stefan Fröhling
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers. Cancer discovery 11 (11) (2021)
Ben Zhao, Laura Dierichs, Jiang-Ning Gu, Marija Trajkovic-Arsic, Ralf Axel Hilger, Konstantinos Savvatakis, Silvia Vega-Rubin-de-Celis, Sven-Thorsten Liffers, Samuel Peña-Llopis, Diana Behrens, Stephan Hahn, Jens Thomas Siveke, Smiths S Lueong
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer. Cell death discovery 6 (2020)
Georgios A Kaissis, Sebastian Ziegelmayer, Fabian K Lohöfer, Felix N Harder, Friederike Jungmann, Daniel Sasse, Alexander Muckenhuber, Hsi-Yu Yen, Katja Steiger, Jens Thomas Siveke, Helmut Friess, Roland Schmid, Wilko Weichert, Marcus R Makowski, Rickmer F Braren
Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma. Journal of clinical medicine 9 (3) (2020)
Britta Tjaden, Katharina Baum, Viktoria Marquardt, Mareike Simon, Marija Trajkovic-Arsic, Theresa Kouril, Bettina Siebers, Jan Lisec, Jens Thomas Siveke, Johannes H Schulte, Uwe Benary, Marc Remke, Jana Wolf, Alexander Schramm
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma. Scientific reports 10 (1) (2020)
Xin Zhang, Tim Zegar, Anais Lucas, Chevaun Morrison-Smith, Tatiana Knox, Christopher A French, Stefan Knapp, Susanne Müller, Jens Thomas Siveke
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma. Oncogene 39 (24) (2020)
Xin Zhang, Tim Zegar, Tim Weiser, Feda H Hamdan, Benedict-Tilman Berger, Romain Lucas, Dimitrios-IIias Balourdas, Swetlana Ladigan-Badura, Phyllis F Cheung, Sven-Thorsten Liffers, Marija Trajkovic-Arsic, Bjoern Scheffler, Andreas C Joerger, Stephan A Hahn, Steven A Johnsen, Stefan Knapp, Jens Thomas Siveke
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. International journal of cancer 147 (10) (2020)
Patricia Johansson, Laura Dierichs, Ludger Klein-Hitpass, Anke K Bergmann, Michael Möllmann, Sascha Menninger, Peter Habenberger, Bert Klebl, Jens Thomas Siveke, Ulrich Dührsen, Axel Choidas, Jan Dürig
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia. Therapeutic advances in hematology 11 (2020)
Sylvie Lorenzen, Jorge Riera Knorrenschild, Claudia Pauligk, Susanna Hegewisch-Becker, Jörg Seraphin, Peter Thuss-Patience, Hans-Georg Kopp, Tobias Dechow, Arndt Vogel, Kim Barbara Luley, Daniel Pink, Michael Stahl, Frank Kullmann, Holger Hebart, Jens Thomas Siveke, Matthias Egger, Nils Homann, Stephan Probst, Thorsten Oliver Goetze, Salah-Eddin Al-Batran
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC). International journal of cancer 147 (9) (2020)
Jörn Weisner, Ina Landel, Christoph Reintjes, Niklas Uhlenbrock, Marija Trajkovic-Arsic, Niklas Dienstbier, Julia Hardick, Swetlana Ladigan, Marius Lindemann, Steven Smith, Lena Quambusch, Rebekka Scheinpflug, Laura Depta, Rajesh Gontla, Anke Unger, Matthias Philipp Müller, Matthias Baumann, Carsten Schultz-Fademrecht, Georgia Günther, Abdelouahid Maghnouj, Michael Pohl, Christian Teschendorf, Heiner Wolters, Richard Viebahn, Andrea Tannapfel, Waldemar Uhl, Jan G Hengstler, Stephan A Hahn, Jens Thomas Siveke, Daniel Rauh
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer. Cancer research 79 (9) (2019)
Lena Quambusch, Ina Landel, Laura Depta, Jörn Weisner, Niklas Uhlenbrock, Matthias P Müller, Franziska Glanemann, Kristina Althoff, Jens Thomas Siveke, Daniel Rauh
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity. Angewandte Chemie (International ed. in English) 58 (52) (2019)
David L Marks, Rachel L Olson, Raul Urrutia, Daniel D Billadeau, Nilotpal Roy, George A Calin, Muller Fabbri, Marina Koutsioumpa, Dimitrios Iliopoulos, Tamas Ordog, Robert C Huebert, Olga Sarmento, Adebowale O Bamidele, William Faubion, Gwen L Lomberk, Jens Thomas Siveke, Nita Ahuja, Juan Lucio Iovanna, Ryan A Hlady, Keith Robertson, John Kisiel, Christopher L Pin, Martin E Fernandez-Zapico
Epigenetics of gastrointestinal diseases: notes from a workshop. Epigenetics 13 (4) (2018)

Jens Thomas Siveke.css-eqlu8i{font-size:small;padding-left:4px;} (Jens T Siveke, Jens Siveke)

Publication Activity (10 Years)

Top Topics

Top Venues

Jens Thomas Siveke (Jens T Siveke, Jens Siveke)